Cowen And Company, LLC Clovis Oncology, Inc. Transaction History

Cowen And Company, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $112,028 - $197,501	-41,492 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.06 - $5.8 $168,457 - $240,653	41,492 New	41,492 $185,000
Q2 2020 Aug 13, 2020	SELL	$5.69 - $9.69 $2.65 Million - $4.51 Million	-465,132 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$3.77 - $11.0 $1.75 Million - $5.12 Million	465,132 New	465,132 $2.96 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.